Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 997

1.

Responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus.

Vital EM, Wittmann M, Edward S, Md Yusof MY, MacIver H, Pease CT, BChir MG, Emery P.

Am J Hematol. 2015 Feb 26. doi: 10.1002/ajh.23993. [Epub ahead of print]

PMID:
25728567
[PubMed - as supplied by publisher]
2.

Responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus.

Vital EM, Wittmann M, Edward S, Yuzaiful M, MacIver H, Pease CT, Goodfield M, Emery P.

Arthritis Rheumatol. 2015 Feb 23. doi: 10.1002/art.39085. [Epub ahead of print]

PMID:
25707733
[PubMed - as supplied by publisher]
3.

The OMERACT MRI in Arthritis Working Group - Update on Status and Future Research Priorities.

Østergaard M, Bird P, Gandjbakhch F, Eshed I, Haugen IK, Haavardsholm EA, Lillegraven S, Foltz V, Glinatsi D, Peterfy C, Ejbjerg B, Bøyesen P, Mease PJ, Hermann KG, Emery P, Genant HK, Conaghan PG.

J Rheumatol. 2015 Feb 15. pii: jrheum.141248. [Epub ahead of print]

PMID:
25684771
[PubMed - as supplied by publisher]
4.

Etanercept tapering in rheumatoid arthritis.

Emery P, Hammoudeh M, Combe B.

N Engl J Med. 2015 Jan 29;372(5):489-90. doi: 10.1056/NEJMc1414787. No abstract available.

PMID:
25629751
[PubMed - indexed for MEDLINE]
Free Article
5.

The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug.

Navarro Coy N, Brown S, Bosworth A, Davies C, Emery P, Everett C, Fernandez C, Gray J, Hartley S, Hulme C, Keenan AM, McCabe C, Redmond A, Reynolds C, Scott D, Sharples LD, Pavitt S, Buch MH.

BMC Musculoskelet Disord. 2014 Dec 23;15(1):452. [Epub ahead of print]

PMID:
25539805
[PubMed - as supplied by publisher]
Free Article
6.

Rheumatoid arthritis in 2014: Exciting times for RA research.

Emery P.

Nat Rev Rheumatol. 2015 Feb;11(2):69-70. doi: 10.1038/nrrheum.2014.216. Epub 2014 Dec 23. No abstract available.

PMID:
25536484
[PubMed - in process]
7.

Modulation of peripheral T-cell function by interleukin-7 in Rheumatoid Arthritis.

Churchman SM, El-Jawhari JJ, Burska AN, Parmar R, Goëb V, Conaghan PG, Emery P, Ponchel F.

Arthritis Res Ther. 2014 Dec 23;16(6):511. [Epub ahead of print]

PMID:
25533722
[PubMed - as supplied by publisher]
Free PMC Article
8.

Sustained remission with etanercept tapering in early rheumatoid arthritis.

Emery P, Hammoudeh M, FitzGerald O, Combe B, Martin-Mola E, Buch MH, Krogulec M, Williams T, Gaylord S, Pedersen R, Bukowski J, Vlahos B.

N Engl J Med. 2014 Nov 6;371(19):1781-92. doi: 10.1056/NEJMoa1316133.

PMID:
25372086
[PubMed - indexed for MEDLINE]
9.

Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period.

Emery P, Burmester GR, Bykerk VP, Combe BG, Furst DE, Barré E, Karyekar CS, Wong DA, Huizinga TW.

Ann Rheum Dis. 2015 Jan;74(1):19-26. doi: 10.1136/annrheumdis-2014-206106. Epub 2014 Nov 3.

PMID:
25367713
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study.

Peterfy C, Emery P, Tak PP, Ostergaard M, DiCarlo J, Otsa K, Navarro Sarabia F, Pavelka K, Bagnard MA, Gylvin LH, Bernasconi C, Gabriele A.

Ann Rheum Dis. 2014 Oct 29. pii: annrheumdis-2014-206015. doi: 10.1136/annrheumdis-2014-206015. [Epub ahead of print]

PMID:
25355728
[PubMed - as supplied by publisher]
Free Article
11.

Musculoskeletal ultrasound in rheumatology in Korea: targeted ultrasound initiative survey.

Kang T, Wakefield RJ, Emery P.

Int J Rheum Dis. 2014 Oct 28. doi: 10.1111/1756-185X.12508. [Epub ahead of print]

PMID:
25351515
[PubMed - as supplied by publisher]
12.

High-resolution MRI assessment of dactylitis in psoriatic arthritis shows flexor tendon pulley and sheath-related enthesitis.

Tan AL, Fukuba E, Halliday NA, Tanner SF, Emery P, McGonagle D.

Ann Rheum Dis. 2015 Jan;74(1):185-9. doi: 10.1136/annrheumdis-2014-205839. Epub 2014 Sep 26.

PMID:
25261575
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Do the European League Against Rheumatism Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?

Lendrem D, Mitchell S, McMeekin P, Gompels L, Hackett K, Bowman S, Price E, Pease CT, Emery P, Andrews J, Lanyon P, Hunter J, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Griffiths B, Ng WF; on behalf of the UK primary Sjögren’s Syndrome Registry.

Rheumatology (Oxford). 2014 Sep 19. pii: keu361. [Epub ahead of print]

PMID:
25240612
[PubMed - as supplied by publisher]
14.

Association between disease activity and risk of serious infections in subjects with rheumatoid arthritis treated with etanercept or disease-modifying anti-rheumatic drugs.

Emery P, Gallo G, Boyd H, Morgan CL, Currie CJ, Poole CD, Nab HW.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):653-60. Epub 2014 Sep 5.

PMID:
25190189
[PubMed - indexed for MEDLINE]
15.
16.

Comprehensive disease control (CDC): what does achieving CDC mean for patients with rheumatoid arthritis?

Emery P, Kavanaugh A, Bao Y, Ganguli A, Mulani P.

Ann Rheum Dis. 2014 Aug 19. pii: annrheumdis-2014-205302. doi: 10.1136/annrheumdis-2014-205302. [Epub ahead of print]

PMID:
25139667
[PubMed - as supplied by publisher]
Free Article
17.

Reply: To PMID 24757132.

Baker JF, Smolen JS, Aletaha D, Shults J, Conaghan PG, Emery P, Baker DG, Ostergaard M.

Arthritis Rheumatol. 2014 Nov;66(11):3245-6. doi: 10.1002/art.38810. No abstract available.

PMID:
25132673
[PubMed - indexed for MEDLINE]
18.

Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example.

Landewé RB, Smolen JS, Weinblatt ME, Emery P, Dougados M, Fleischmann R, Aletaha D, Kavanaugh A, van der Heijde D.

Ann Rheum Dis. 2014 Oct;73(10):1755-60. doi: 10.1136/annrheumdis-2014-205821. Epub 2014 Aug 11.

PMID:
25114058
[PubMed - indexed for MEDLINE]
19.

Biologics in rheumatoid arthritis: where are we going?

Fechtenbaum M, Nam JL, Emery P.

Br J Hosp Med (Lond). 2014 Aug;75(8):448-9, 451-6. doi: 10.12968/hmed.2014.75.8.448. Review.

PMID:
25111096
[PubMed - indexed for MEDLINE]
20.

Biologics in systemic lupus erythematosus: current options and future perspectives.

Md Yusof MY, Vital EM, Emery P.

Br J Hosp Med (Lond). 2014 Aug;75(8):440, 442-7. doi: 10.12968/hmed.2014.75.8.440. Review.

PMID:
25111095
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk